Cite
HARVARD Citation
Barrow, P. et al. (2019). Confirmation that somatic mutations of beta‐2 microglobulin correlate with a lack of recurrence in a subset of stage II mismatch repair deficient colorectal cancers from the QUASAR trial. Histopathology. 75 (2), pp. 236-246. [Online].